Biortica executive quits cannabis to return to pharma sector by Steve Jones February 4, 2026February 5, 2026 Biortica Agrimed chief strategy officer Shane Duncan has quit the firm – and medicinal cannabis – […]
Cash running dry, consolidation on the cards but market remains ‘primed for growth’, industry leaders predict by Steve Jones March 16, 2024March 16, 2024
Former Cann Group executive Shane Duncan to plot acquisition strategy for Biortica Agrimed by Steve Jones March 13, 2024March 13, 2024
Business leaders must ‘park the ego’ to accelerate local production by Steve Jones August 30, 2023August 30, 2023
Cann Group COO Shane Duncan quits after four ‘challenging and exciting years’ by Steve Jones January 23, 2023January 23, 2023
We’ve put our money where our mouth is, says Cann Group as focus turns to generating revenue by Steve Jones November 11, 2022April 29, 2024
Cann Group looks to raise another A$10m for Mildura, puts Southern facility up for sale by Martin Lane October 25, 2022April 29, 2024
Avecho chief warns of placebo dangers as firms roll out CBD clinical trials by Steve Jones October 20, 2022April 29, 2024
Modern medicine: can the dominance of oil and flower be challenged? by Steve Jones October 6, 2022April 29, 2024
